Filing Details
- Accession Number:
- 0001179110-14-015112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-03 20:23:15
- Reporting Period:
- 2014-10-01
- Filing Date:
- 2014-10-03
- Accepted Time:
- 2014-10-03 20:23:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578962 | Walter Stuart Peltz | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-10-01 | 19,900 | $42.09 | 116,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 18,621 | $43.06 | 97,381 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-01 | 2,980 | $43.89 | 94,401 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $41.74 to $42.74 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $42.75 to $43.75 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.78 to $44.10 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
